[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.12.79. Please contact the publisher to request reinstatement.
[Skip to Content Landing]

Year

Day

January 15, 2020
Original Investigation

Sex Differences in Blood Pressure Trajectories Over the Life Course

Abstract Full Text
has audio
JAMA Cardiol. Published online January 15, 2020. doi:10.1001/jamacardio.2019.5306

This study evaluates whether longitudinal patterns of blood pressure elevation differ between women and men during the life course when considering baseline blood pressure levels as the reference.

Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial

Abstract Full Text
open access
JAMA Cardiol. Published online January 15, 2020. doi:10.1001/jamacardio.2019.5323

This prespecified secondary analysis of the MOMENTUM 3 randomized clinical trial aims to determine whether clinical outcomes of patients with 2 different left ventricular assist devices differed based on preoperative categories of bridge to transplant/bridge to candidacy vs destination therapy.

Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of ERBB2-Positive Breast Cancer

Abstract Full Text
JAMA Cardiol. Published online January 15, 2020. doi:10.1001/jamacardio.2019.5586

This cross-sectional study assesses whether treatment-induced cardiotoxicity is associated with long-term cardiopulmonary dysfunction in survivors of ERBB2-positive breast cancer.

Editorial

Adverse Cardiovascular Outcomes for Women—Biology, Bias, or Both?

Abstract Full Text
has audio
JAMA Cardiol. Published online January 15, 2020. doi:10.1001/jamacardio.2019.5576

At Last, One Indication for Left Ventricular Assist Devices—A Bridge to a Better and Longer Life

Abstract Full Text
JAMA Cardiol. Published online January 15, 2020. doi:10.1001/jamacardio.2019.5592
Cardiovascular Images

A Man in His 40s With Coronary-to-Pulmonary Artery Collateralizations

Abstract Full Text
has multimedia
JAMA Cardiol. Published online January 15, 2020. doi:10.1001/jamacardio.2019.5289

This case report describes coronary-to-pulmonary artery collateralizations in chronic thromboembolic pulmonary hypertension.

January 8, 2020
Original Investigation

Usefulness of Routine Fractional Flow Reserve for Clinical Management of Coronary Artery Disease in Patients With Diabetes

Abstract Full Text
JAMA Cardiol. Published online January 8, 2020. doi:10.1001/jamacardio.2019.5097

This cross-sectional study evaluates the association of major adverse cardiac events (MACE) integrated with fractional flow reserve as the management strategy for diabetes with outcomes in patients with ambiguous lesions who undergo angiography.

Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart Failure

Abstract Full Text
JAMA Cardiol. Published online January 8, 2020. doi:10.1001/jamacardio.2019.5108

This cohort study compares the characteristics and management of acute heart failure in global regions comprising 44 countries.

Polygenic Risk, Fitness, and Obesity in the Coronary Artery Risk Development in Young Adults (CARDIA) Study

Abstract Full Text
JAMA Cardiol. Published online January 8, 2020. doi:10.1001/jamacardio.2019.5220

This cohort study quantifies the relative importance of a polygenic risk score, fitness, activity, parental history of overweight, and body mass index in young adulthood regarding body mass index trends over 25 years.

Temporal Trends in Racial Differences in 30-Day Readmission and Mortality Rates After Acute Myocardial Infarction Among Medicare Beneficiaries

Abstract Full Text
JAMA Cardiol. Published online January 8, 2020. doi:10.1001/jamacardio.2019.4845

This cohort study assesses temporal trends in 30-day readmission and mortality rates among black and nonblack patients discharged after hospitalization for acute myocardial infarction at hospitals defined as low-performing and high-performing per their Hospital Readmissions Reduction Program penalty status.

Brief Report

Identification of a Novel Homozygous Multi-Exon Duplication in RYR2 Among Children With Exertion-Related Unexplained Sudden Deaths in the Amish Community

Abstract Full Text
JAMA Cardiol. Published online January 8, 2020. doi:10.1001/jamacardio.2019.5400

This study investigates the underlying cause of multiple sudden deaths and sudden cardiac arrests that occurred in children of 2 large Amish families.

Viewpoint

Tafamidis—A Pricey Therapy for a Not-So-Rare Condition

Abstract Full Text
JAMA Cardiol. Published online January 8, 2020. doi:10.1001/jamacardio.2019.5233

The Viewpoint highlights the high price of treatment with tafamidis for people with transthyretin amyloidosis in the United States.

Invited Commentary

Racial Disparities in Readmission Rates Following Acute Myocardial Infarction in the Hospital Readmissions Reduction Program Era

Abstract Full Text
JAMA Cardiol. Published online January 8, 2020. doi:10.1001/jamacardio.2019.5120
Comment & Response

Using Perivascular Fat Attenuation Index to Monitor Coronary Inflammation in Patients With Psoriasis

Abstract Full Text
JAMA Cardiol. Published online January 8, 2020. doi:10.1001/jamacardio.2019.5236

Using Perivascular Fat Attenuation Index to Monitor Coronary Inflammation in Patients With Psoriasis—Reply

Abstract Full Text
JAMA Cardiol. Published online January 8, 2020. doi:10.1001/jamacardio.2019.5333
January 2, 2020
Original Investigation

Safety and Efficacy of Femoral Access vs Radial Access in ST-Segment Elevation Myocardial Infarction: The SAFARI-STEMI Randomized Clinical Trial

Abstract Full Text
JAMA Cardiol. Published online January 2, 2020. doi:10.1001/jamacardio.2019.4852

This multicenter randomized clinical trial conducted in Canada assesses whether 30-day all-cause mortality differs with the use of radial access or femoral access for primary percutaneous coronary intervention among referred patients with ST-segment elevation myocardial infarction.

Brief Report

Eligibility and Preventive Potential for New Evidence-Based Cardiovascular Drugs in Secondary Prevention

Abstract Full Text
JAMA Cardiol. Published online January 2, 2020. doi:10.1001/jamacardio.2019.4759

This cohort study examines the drug eligibility of 12 cardiovascular drugs recently tested in several randomized clinical trials for Danish patients with known ischemic heart disease or prior myocardial infarction.

Invited Commentary

Comparing Percutaneous Coronary Intervention Access Sites for ST-Elevation Myocardial Infarction—Are Radial and Femoral Access Equally Safe?

Abstract Full Text
JAMA Cardiol. Published online January 2, 2020. doi:10.1001/jamacardio.2019.5356

Translating the Secondary Prevention Therapeutic Boom Into Action

Abstract Full Text
JAMA Cardiol. Published online January 2, 2020. doi:10.1001/jamacardio.2019.4959
Special Communication

Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action

Abstract Full Text
JAMA Cardiol. Published online January 2, 2020. doi:10.1001/jamacardio.2019.5173

This guideline presents updated recommendations for management of familial hypercholesterolemia.

Comment & Response

Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older

Abstract Full Text
JAMA Cardiol. Published online January 2, 2020. doi:10.1001/jamacardio.2019.5197

Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older

Abstract Full Text
JAMA Cardiol. Published online January 2, 2020. doi:10.1001/jamacardio.2019.5200

Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older—Reply

Abstract Full Text
JAMA Cardiol. Published online January 2, 2020. doi:10.1001/jamacardio.2019.5241
×